SOLEXA
Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.
SOLEXA
Industry:
Biotechnology Genetics Medical Medical Device
Founded:
1998-01-01
Address:
Hayward, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
222.9 M USD
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Azimuth Opportunity
Azimuth Opportunity investment in Post-IPO Equity - Solexa
ValueAct Capital
ValueAct Capital investment in Private Equity Round - Solexa
Schroder Ventures
Schroder Ventures investment in Series B - Solexa
Amadeus Capital Partners
Amadeus Capital Partners investment in Series B - Solexa
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Solexa
Abingworth
Abingworth investment in Series B - Solexa
Schroder Ventures
Schroder Ventures investment in Series A - Solexa
SV Health Investors
SV Health Investors investment in Venture Round - Solexa